Form D · Other Health Care
NXTHERA INC
Maple Grove, MN · CIK 0001436280
Offering snapshot reported Jul 19, 2017 · SEC filing
- Reported sold
- $20.6M Offering amount: $26.4M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$14,590,169 → $20,607,854
- Reported investors29 → 31
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 19, 2017 | Amendment | $20,607,854 | $6,017,685vs Mar 3, 2017 | 31 | SEC filing |
| Mar 3, 2017 | Amendment | $14,590,169 | $2,355,973vs Feb 3, 2017 | 29 | SEC filing |
| Feb 3, 2017 | Initial | $12,234,196 | No comparison | 28 | SEC filing |
| Dec 10, 2015 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
| Dec 10, 2015 | Initial | $8,264,260 | No comparison | 28 | SEC filing |
| Feb 11, 2015 | Initial | $3,000,000 | No comparison | 26 | SEC filing |
| Sep 30, 2013 | Initial | $6,575,000 | No comparison | 20 | SEC filing |
| Apr 11, 2013 | Initial | $3,500,000 | No comparison | 17 | SEC filing |
| Aug 31, 2011 | Amendment | $14,627,300 | $5,927,300vs Mar 8, 2011 | 13 | SEC filing |
| Mar 8, 2011 | Initial | $8,700,000 | No comparison | 6 | SEC filing |
| Feb 8, 2011 | Amendment | $2,500,000 | $500,000vs Nov 1, 2010 | 5 | SEC filing |
| Nov 1, 2010 | Amendment | $2,000,000 | $1,000,000vs Aug 2, 2010 | 5 | SEC filing |
| Aug 2, 2010 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| Nov 17, 2009 | Initial | $3,000,000 | No comparison | 4 | SEC filing |
| May 23, 2008 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280003
Amount sold does not include foreign purchasers
Convertible Promissory Notes and Series C Preferred Stock Warrants
Source: Form D, filed Jul 19, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carmen L. Bringgold | Executive |
| Charles Chon | Director |
| Mark Christopherson | Executive |
| Mona Dahdah | Executive |
| Andre De Bruin | Director |
| Patrick Fabian | Executive |
| Patrick Fabien | Executive |
| Maximillian Fiore | Director, Executive |
| Jan Garfinkle | Director |
| Brian Gustafson | Director |
| Sami Hamade | Director |
| Michael Hoey | Director, Executive |
| Michael Kujak | Executive |
| Thomas Lowe | Director |
| Tom Lowe | Director |
| Glen Nelson | Director |
| Cindy Ogden | Executive |
| J. Robert Paulson | Director, Executive |
| J. Robert Paulson | Director, Executive |
| Sigrid Van Bladel, Ph.D | Director |
| Carmen B. Volkhart | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7351 Kirkwood Lane Suite 138
Maple Grove, MN, 55369
Maple Grove, MN, 55369